Asitri Dashboard
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 304
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT00582244 | Cognitive Behavioral Therapy (CBT) and Physical Exercise for Climacteric Symptoms in Breast Cancer Patients Experiencing Treatment-Induced Menopause: a Multicenter Randomized Trial | ||
NCT02672189 | Internet-based Cognitive Behavioral Therapy for Breast Cancer Patients With Climacteric Symptoms | ||
NCT03819829 | Blood Sampling of Healthy Volunteers for Immunological Research | ||
NCT04574427 | INtra-operative Evaluation of a Novel FLUorescENt C-mEt Tracer in Penile and Tongue | ||
NCT03223727 | Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223 | ||
NCT03305965 | The Effectiveness of Patient Navigation in Cancer Care | ||
NCT02227082 | Olaparib and Radiotherapy in Inoperable Breast Cancer | ||
NCT01024582 | Radiation Therapy Followed by Surgery in Treating Patients With Early-Stage Breast Cancer | ||
NCT04133948 | Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma | ||
NCT06279130 | Pan-tumor Neoadjuvant Basket Study of Immune Check-point Inhibition and Novel Immuno-oncology Combinations | ||
NCT06329648 | Distributed Learning of Edic and CardIac Dose Effects in Lung Cancer | ||
NCT03048474 | Ipilimumab and Nivolumab in the Treatment of Malignant Pleural Mesothelioma | ||
NCT02836548 | HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma | ||
NCT04330430 | Neo-adjuvant T-VEC + Nivolumab Combination Therapy for Resectable Early Metastatic (Stage IIIB/C/D-IV M1a) Melanoma With Injectable Disease | ||
NCT02276430 | TACkLE Study - Tackling Adverse Chemotherapy-associated Late Effects | ||
NCT05406674 | Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer | ||
NCT02091765 | RCT of an Internet-based CBT Program for Sexuality and Intimacy Problems in Women Treated for Breast Cancer | ||
NCT04148066 | ctDNA Guided Treatment of Early Resistance to Targeted Treatment | ||
NCT04998474 | FRAME-001 Personalized Vaccine in NSCLC | ||
NCT02575066 | Clinical Study of Concurrent Pazopanib and Radiotherapy for Non-metastatic Sarcoma Patients | ||
NCT01562431 | The Signal-Trial: Evaluation of a Screening Tool for Psychosocial Problems in Cancer Genetics | ||
NCT04737382 | Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed. | ||
NCT06364631 | CARE1 Pragmatic Clinical Trial | ||
NCT06634173 | The Diagnostic Value of FAPI PET/CT in Staging of Newly Diagnosed Prostate Cancer | ||
NCT02938273 | Bioimmunoradiotherapy (Cetuximab/RT/Avelumab) | ||
NCT02485626 | Identifying Subgroups With High Cardiovascular Risk in Breast Cancer Survivors | ||
NCT02934126 | The Development of a Personalized Decision Aid: Perspectives of Patients and Health Care Professionals on Shared Decision Making and Informational Needs on Radiotherapy for Breast Cancer | ||
NCT00426257 | Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer | ||
NCT03540420 | Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer | ||
NCT06237920 | Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab | ||
NCT00448266 | Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD | ||
NCT04813965 | Breast Cancer Patients' Cognitive Symptoms After Information About Chemotherapy-Related Cognitive Symptoms | ||
NCT03295565 | Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel | ||
NCT00743262 | Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis | ||
NCT04699292 | International Prospective Registry on Local Treatment Approaches in MLS | ||
NCT04287829 | Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients | ||
NCT03482362 | Vinorelbine in Advanced BRAF-like Colon Cancer | ||
NCT04871594 | Pre-operative Immunotherapy in Stage II-III Urothelial Cancer | ||
NCT06514560 | OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis Patients | ||
NCT01795976 | NY-ESO-1 T Cells in OG Cancer | ||
NCT05529927 | Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder | ||
NCT04393376 | PSA Glycomics Assay for Early Detection of Prostate Cancer | ||
NCT04287894 | Assess the Safety of Immunotherapy Induction With Tremelimumab and Durvalumab Prior to Chemoradiotherapy and/or Resection in the Treatment | ||
NCT05162573 | EBRT + Lu-PSMA for N1M0 Prostate Cancer | ||
NCT05120973 | Multispectral Fluorescence as a Tool to Separate Healthy and Disease Related Lymphatic Anatomies in Prostate Cancer. | ||
NCT04022863 | Ovarium Cancer Detection by TEP's and ctDNA | ||
NCT00783822 | Effects of Rapid Genetic Counseling and Testing in Newly Diagnosed Breast Cancer Patients | ||
NCT05401786 | Anti-PD-1 Re-challenge After Immune Priming by Ipilimumab and Immune Boosting by Radiotherapy in Advanced NSCLC | ||
NCT05079386 | Clinical Feasibility of a New Voice Prosthesis | ||
NCT03448835 | Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA) |